An observational study in Cholecystectomy, sponsored by Distalmotion SA. Completed at 4 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Distalmotion SA · Observational
Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multi…PubMed 40973903 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing robotic-assisted and laparoscopic cholecystectomy.
Distalmotion SA is the lead sponsor of 9 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients undergoing a cholecystectomy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Robotic-assisted and laparoscopic cholecystectomy
primary safety endpoint
occurrence of Clavien - Dindo grades III-V adverse events
Time frame: up to 30 days
primary performance endpoint
successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
Time frame: intraoperative
Plan to share: No
Ran from Jun 2024 to primary completion in Dec 2024, 6 months.
How these figures are worked out, and which studies are left out of them.
Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multi…PubMed 40973903 ↗
Seeger N, Mignot H, Matthaei H, Gantner L, Kuchen N, O'Sullivan O, Breitenstein S. Robotic-assisted cholecystectomy with DEXTER(R): the first prospective multi…PubMed 40973903 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Distalmotion SA